CRP and COVID-19: Interestingly, the diagnostic protocols for patients with severe COVID-19 (e.g., measuring inflammatory markers such as CRP and procalcitonin [PCT]) may, in some cases, have contributed to faster TC detection, particularly for medullary thyroid cancer (MTC).